Biotransformation of doxorubicin, daunorubicin, and idarubicin in human liver microsomal fraction and by novel human liver microsomal carbonyl reductase was done. Results obtained for the biotransformation of anthracyclines in human liver microsomal fraction indicate that there are two possible pathways for their metabolism.